Ayyappan K. Rajasekaran - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
Cell Biology, Molecular Biology

58/82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hao Y, Song J, Ravikrishnan A, Dicker KT, Fowler EW, Zerdoum AB, Li Y, Zhang H, Rajasekaran AK, Fox JM, Jia X. Rapid Bioorthogonal Chemistry Enables in Situ Modulation of Stem Cell Behavior in 3D without External Triggers. Acs Applied Materials & Interfaces. PMID 30015482 DOI: 10.1021/Acsami.8B07632  0.328
2016 Hao Y, Zerdoum AB, Stuffer AJ, Rajasekaran AK, Jia X. Biomimetic Hydrogels Incorporating Polymeric Cell-Adhesive Peptide to Promote the 3D Assembly of Tumoroids. Biomacromolecules. PMID 27723964 DOI: 10.1021/Acs.Biomac.6B01266  0.335
2016 Ravikrishnan A, Ozdemir T, Bah MA, Baskerville KA, Shah SI, Rajasekaran AK, Jia X. Regulation of Epithelial-to-Mesenchymal Transition Using Biomimetic Fibrous Scaffolds. Acs Applied Materials & Interfaces. PMID 27322677 DOI: 10.1021/Acsami.6B05646  0.386
2015 David JM, Rajasekaran AK. Gramicidin A: A New Mission for an Old Antibiotic. Journal of Kidney Cancer and Vhl. 2: 15-24. PMID 28326255 DOI: 10.15586/Jkcvhl.2015.21  0.312
2015 Patil PU, D'Ambrosio J, Inge LJ, Mason RW, Rajasekaran AK. Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR. Journal of Cell Science. 128: 4366-79. PMID 26483386 DOI: 10.1242/Jcs.173518  0.72
2015 Huynh TP, Barwe SP, Lee SJ, McSpadden R, Franco OE, Hayward SW, Damoiseaux R, Grubbs SS, Petrelli NJ, Rajasekaran AK. Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression. Plos One. 10: e0122442. PMID 25836370 DOI: 10.1371/Journal.Pone.0122442  0.376
2015 Patil P, Mason RW, Ambrosio JD, Rajasekaran AK. Abstract LB-032: Soluble E-cadherin as a microenvironmental factor that enhances tumor progression Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-032  0.426
2014 Sampson VB, David JM, Puig I, Patil PU, de Herreros AG, Thomas GV, Rajasekaran AK. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma. Plos One. 9: e102041. PMID 25025131 DOI: 10.1371/Journal.Pone.0102041  0.422
2014 David JM, Owens TA, Inge LJ, Bremner RM, Rajasekaran AK. Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma. Molecular Cancer Therapeutics. 13: 788-99. PMID 24493697 DOI: 10.1158/1535-7163.Mct-13-0891  0.703
2014 Selvakumar P, Owens TA, David JM, Petrelli NJ, Christensen BC, Lakshmikuttyamma A, Rajasekaran AK. Epigenetic silencing of Na,K-ATPase β 1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma. Epigenetics. 9: 579-86. PMID 24452105 DOI: 10.4161/Epi.27795  0.429
2013 David JM, Owens TA, Barwe SP, Rajasekaran AK. Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells. Molecular Cancer Therapeutics. 12: 2296-307. PMID 24006494 DOI: 10.1158/1535-7163.Mct-13-0445  0.399
2013 David JM, Rajasekaran AK. Abstract 3451: Gramicidin-based nanopores induce cellular energy depletion and cell death in renal cell carcinoma. Cancer Research. 73: 3451-3451. DOI: 10.1158/1538-7445.Am2013-3451  0.388
2012 Barwe SP, Skay A, McSpadden R, Huynh TP, Langhans SA, Inge LJ, Rajasekaran AK. Na,K-ATPase β-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells. Journal of Cell Science. 125: 5711-20. PMID 23077177 DOI: 10.1242/Jcs.108795  0.707
2012 David JM, Rajasekaran AK. Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Cancer Research. 72: 2917-23. PMID 22659456 DOI: 10.1158/0008-5472.Can-11-3498  0.385
2012 Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK. Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. American Journal of Physiology. Lung Cellular and Molecular Physiology. 302: L1150-8. PMID 22345575 DOI: 10.1152/Ajplung.00384.2010  0.394
2011 Inge LJ, Barwe SP, D'Ambrosio J, Gopal J, Lu K, Ryazantsev S, Rajasekaran SA, Rajasekaran AK. Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor. Experimental Cell Research. 317: 838-48. PMID 21211535 DOI: 10.1016/J.Yexcr.2010.12.025  0.69
2010 Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, Lassman C, Nicholas SB, Harper JF, Reeves AE, Ahmed MM, Leatherman JM, Mullin JM, Rajasekaran AK. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Molecular Cancer Therapeutics. 9: 1515-24. PMID 20501797 DOI: 10.1158/1535-7163.Mct-09-0832  0.767
2009 Barwe SP, Jordan MC, Skay A, Inge L, Rajasekaran SA, Wolle D, Johnson CL, Neco P, Fang K, Rozengurt N, Goldhaber JI, Roos KP, Rajasekaran AK. Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit. Journal of Molecular and Cellular Cardiology. 47: 552-60. PMID 19683723 DOI: 10.1016/J.Yjmcc.2009.07.018  0.721
2009 Tummala R, Wolle D, Barwe SP, Sampson VB, Rajasekaran AK, Pendyala L. Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin. Cancer Chemotherapy and Pharmacology. 64: 1187-94. PMID 19322565 DOI: 10.1007/S00280-009-0985-X  0.497
2009 Rajasekaran SA, Rajasekaran AK. Na,K-ATPase and epithelial tight junctions. Frontiers in Bioscience (Landmark Edition). 14: 2130-48. PMID 19273189 DOI: 10.2741/3367  0.384
2008 Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, Weinstein J, Rao NP, Rajasekaran AK. Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Molecular Cancer Therapeutics. 7: 2142-51. PMID 18645024 DOI: 10.1158/1535-7163.Mct-08-0005  0.72
2008 Inge LJ, Rajasekaran SA, Wolle D, Barwe SP, Ryazantsev S, Ewing CM, Isaacs WB, Rajasekaran AK. alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling. Molecular Cancer Therapeutics. 7: 1386-97. PMID 18566211 DOI: 10.1158/1535-7163.Mct-07-2029  0.75
2008 Reckamp KL, Gardner BK, Figlin RA, Elashoff D, Krysan K, Dohadwala M, Mao J, Sharma S, Inge L, Rajasekaran A, Dubinett SM. Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 117-24. PMID 18303430 DOI: 10.1097/Jto.0B013E3181622Bef  0.685
2008 Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, Rajasekaran AK. Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit. Histology and Histopathology. 23: 459-67. PMID 18228203 DOI: 10.14670/Hh-23.459  0.765
2008 Rajasekaran SA, Beyenbach KW, Rajasekaran AK. Interactions of tight junctions with membrane channels and transporters. Biochimica Et Biophysica Acta. 1778: 757-69. PMID 18086552 DOI: 10.1016/J.Bbamem.2007.11.007  0.328
2008 Seligson DB, Rajasekaran SA, Yu H, Liu X, Eeva M, Tze S, Ball W, Horvath S, deKernion JB, Rajasekaran AK. Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. The Journal of Urology. 179: 338-45. PMID 18006011 DOI: 10.1016/J.Juro.2007.08.094  0.5
2007 Olson WC, Heston WDW, Rajasekaran AK. Clinical trials of cancer therapies targeting prostate-specific membrane antigen Reviews On Recent Clinical Trials. 2: 182-190. PMID 18474004 DOI: 10.2174/157488707781662724  0.384
2007 Goodman OB, Barwe SP, Ritter B, McPherson PS, Vasko AJ, Keen JH, Nanus DM, Bander NH, Rajasekaran AK. Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2. International Journal of Oncology. 31: 1199-203. PMID 17912448 DOI: 10.3892/Ijo.31.5.1199  0.352
2007 Barwe SP, Maul RS, Christiansen JJ, Anilkumar G, Cooper CR, Kohn DB, Rajasekaran AK. Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix. International Journal of Oncology. 30: 899-904. PMID 17332929 DOI: 10.3892/Ijo.30.4.899  0.709
2007 Cui X, Zhang L, Luo J, Rajasekaran A, Hazra S, Cacalano N, Dubinett SM. Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer. Oncogene. 26: 4253-60. PMID 17237818 DOI: 10.1038/Sj.Onc.1210222  0.35
2007 Barwe SP, Kim S, Rajasekaran SA, Bowie JU, Rajasekaran AK. Janus Model of The Na,K-ATPase β-Subunit Transmembrane Domain: Distinct Faces Mediate α/β Assembly and β-β Homo-oligomerization Journal of Molecular Biology. 365: 706-714. PMID 17078968 DOI: 10.1016/J.Jmb.2006.10.029  0.478
2007 Rajasekaran SA, Barwe SP, Gopal J, Ryazantsev S, Schneeberger EE, Rajasekaran AK. Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 292: G124-33. PMID 16959951 DOI: 10.1152/Ajpgi.00297.2006  0.426
2007 Reckamp KL, Gardner BK, Elashoff D, Figlin RA, Krysan K, Dohadwala M, Inge L, Rajasekaran A, Dubinett SM. P3-033: Serum biomarkers predict response to combination celecoxib and erlotinib therapy in advanced non-small cell lung cancer Journal of Thoracic Oncology. 2: S621. DOI: 10.1097/01.Jto.0000283790.42985.55  0.654
2006 Christiansen JJ, Weimbs T, Bander N, Rajasekaran AK. Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen. Molecular Cancer Therapeutics. 5: 2468-73. PMID 17041090 DOI: 10.1158/1535-7163.Mct-06-0253  0.714
2006 Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research. 66: 8319-26. PMID 16951136 DOI: 10.1158/0008-5472.Can-06-0410  0.693
2006 Anilkumar G, Barwe SP, Christiansen JJ, Rajasekaran SA, Kohn DB, Rajasekaran AK. Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature. Microvascular Research. 72: 54-61. PMID 16713605 DOI: 10.1016/J.Mvr.2006.03.004  0.73
2006 Liu W, Konduri SD, Bansal S, Nayak BK, Rajasekaran SA, Karuppayil SM, Rajasekaran AK, Das GM. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. The Journal of Biological Chemistry. 281: 9837-40. PMID 16469747 DOI: 10.1074/Jbc.C600001200  0.323
2005 Rajasekaran SA, Barwe SP, Rajasekaran AK. Multiple functions of Na,K-ATPase in epithelial cells. Seminars in Nephrology. 25: 328-34. PMID 16139688 DOI: 10.1016/J.Semnephrol.2005.03.008  0.474
2005 Christiansen JJ, Rajasekaran SA, Inge L, Cheng L, Anilkumar G, Bander NH, Rajasekaran AK. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Molecular Cancer Therapeutics. 4: 704-14. PMID 15897234 DOI: 10.1158/1535-7163.Mct-04-0171  0.778
2005 Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? American Journal of Physiology. Cell Physiology. 288: C975-81. PMID 15840561 DOI: 10.1152/Ajpcell.00506.2004  0.712
2005 Barwe SP, Anilkumar G, Moon SY, Zheng Y, Whitelegge JP, Rajasekaran SA, Rajasekaran AK. Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Molecular Biology of the Cell. 16: 1082-94. PMID 15616195 DOI: 10.1091/Mbc.E04-05-0427  0.489
2005 Kim G, Rajasekaran SA, Thomas G, Rosen EA, Landaw EM, Shintaku P, Lassman C, Said J, Rajasekaran AK. Renal clear-cell carcinoma: an ultrastructural study on the junctional complexes. Histology and Histopathology. 20: 35-44. PMID 15578420 DOI: 10.14670/Hh-20.35  0.383
2004 Christiansen J, Rajasekaran AK. Biological impediments to monoclonal antibody-based cancer immunotherapy. Molecular Cancer Therapeutics. 3: 1493-501. PMID 15542788  0.651
2004 Rajasekaran SA, Gopal J, Espineda C, Ryazantsev S, Schneeberger EE, Rajasekaran AK. HPAF-II, a cell culture model to study pancreatic epithelial cell structure and function. Pancreas. 29: e77-83. PMID 15367897 DOI: 10.1097/00006676-200410000-00016  0.754
2004 Rajasekaran SA, Gopal J, Willis D, Espineda C, Twiss JL, Rajasekaran AK. Na,K-ATPase beta1-subunit increases the translation efficiency of the alpha1-subunit in MSV-MDCK cells. Molecular Biology of the Cell. 15: 3224-32. PMID 15133131 DOI: 10.1091/Mbc.E04-03-0222  0.78
2004 Espineda CE, Chang JH, Twiss J, Rajasekaran SA, Rajasekaran AK. Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Molecular Biology of the Cell. 15: 1364-73. PMID 14699059 DOI: 10.1091/Mbc.E03-09-0646  0.791
2004 Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Laboratory Investigation; a Journal of Technical Methods and Pathology. 84: 8-20. PMID 14631378 DOI: 10.1038/Labinvest.3700003  0.306
2003 Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, Heston W, Bander NH, Rajasekaran AK. A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen Molecular Biology of the Cell. 14: 4835-4845. PMID 14528023 DOI: 10.1091/Mbc.E02-11-0731  0.353
2003 Rajasekaran AK, Rajasekaran SA. Role of Na-K-ATPase in the assembly of tight junctions. American Journal of Physiology. Renal Physiology. 285: F388-96. PMID 12890662 DOI: 10.1152/Ajprenal.00439.2002  0.406
2003 Rajasekaran SA, Gopal J, Rajasekaran AK. Expression of Na,K-ATPase beta-subunit in transformed MDCK cells increases the translation of the Na,K-ATPase alpha-subunit. Annals of the New York Academy of Sciences. 986: 652-4. PMID 12763913 DOI: 10.1111/J.1749-6632.2003.Tb07277.X  0.484
2003 Rajasekaran AK, Gopal J, Rajasekaran SA. Na,K-ATPase in the regulation of epithelial cell structure. Annals of the New York Academy of Sciences. 986: 649-51. PMID 12763912 DOI: 10.1111/J.1749-6632.2003.Tb07276.X  0.42
2003 Anilkumar G, Rajasekaran SA, Wang S, Hankinson O, Bander NH, Rajasekaran AK. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Research. 63: 2645-8. PMID 12750292  0.311
2003 Espineda C, Seligson DB, James Ball W, Rao J, Palotie A, Horvath S, Huang Y, Shi T, Rajasekaran AK. Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer. 97: 1859-68. PMID 12673711 DOI: 10.1002/Cncr.11267  0.785
2003 Christiansen JJ, Rajasekaran SA, Moy P, Butch A, Goodglick L, Gu Z, Reiter RE, Bander NH, Rajasekaran AK. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. The Prostate. 55: 9-19. PMID 12640656 DOI: 10.1002/Pros.10203  0.716
2003 Rajasekaran SA, Hu J, Gopal J, Gallemore R, Ryazantsev S, Bok D, Rajasekaran AK. Na,K-ATPase inhibition alters tight junction structure and permeability in human retinal pigment epithelial cells. American Journal of Physiology. Cell Physiology. 284: C1497-507. PMID 12570983 DOI: 10.1152/Ajpcell.00355.2002  0.415
2001 Rajasekaran SA, Palmer LG, Moon SY, Peralta Soler A, Apodaca GL, Harper JF, Zheng Y, Rajasekaran AK. Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Molecular Biology of the Cell. 12: 3717-32. PMID 11739775 DOI: 10.1091/Mbc.12.12.3717  0.431
2001 Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ, Bander NH, Peralta Soler A, Rajasekaran AK. Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Molecular Biology of the Cell. 12: 279-95. PMID 11179415 DOI: 10.1091/Mbc.12.2.279  0.534
1999 Rajasekaran SA, Ball WJ, Bander NH, Liu H, Pardee JD, Rajasekaran AK. Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. The Journal of Urology. 162: 574-80. PMID 10411090 DOI: 10.1016/S0022-5347(05)68629-6  0.469
Low-probability matches (unlikely to be authored by this person)
2018 Liu S, Moore AC, Zerdoum AB, Zhang H, Scinto SL, Zhang H, Gong L, Burris DL, Rajasekaran AK, Fox JM, Jia X. Cellular interactions with hydrogel microfibers synthesized via interfacial tetrazine ligation. Biomaterials. 180: 24-35. PMID 30014964 DOI: 10.1016/J.Biomaterials.2018.06.042  0.294
1996 Rajasekaran AK, Hojo M, Huima T, Rodriguez-Boulan E. Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. The Journal of Cell Biology. 132: 451-63. PMID 8636221 DOI: 10.1083/Jcb.132.3.451  0.275
2011 Presson AP, Yoon NK, Bagryanova L, Mah V, Alavi M, Maresh EL, Rajasekaran AK, Goodglick L, Chia D, Horvath S. Protein expression based multimarker analysis of breast cancer samples. Bmc Cancer. 11: 230. PMID 21651811 DOI: 10.1186/1471-2407-11-230  0.27
2013 Krishnan V, Xu X, Barwe S, Yang X, Waldman SA, Mason RW, Jia X, Rajasekaran AK. Abstract 4520: Nanotechnology based drug delivery in childhood leukemia therapy: A novel approach to reduce side-effects. Cancer Research. 73: 4520-4520. DOI: 10.1158/1538-7445.Am2013-4520  0.268
2010 Vivanco I, Rohle D, Versele M, Iwanami A, Kuga D, Oldrini B, Tanaka K, Dang J, Kubek S, Palaskas N, Hsueh T, Evans M, Mulholland D, Wolle D, Rajasekaran S, ... Rajasekaran A, et al. The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation. Proceedings of the National Academy of Sciences of the United States of America. 107: 6459-64. PMID 20308550 DOI: 10.1073/Pnas.0911188107  0.263
2014 Krishnan V, Rajasekaran AK. Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy. Clinical Pharmacology and Therapeutics. 95: 168-78. PMID 24013811 DOI: 10.1038/Clpt.2013.174  0.259
1997 Banerjee D, Rodriguez M, Rajasekaran AK. Rapid movement of newly synthesized chicken apolipoprotein AI to trans-Golgi network and its secretion in Madin-Darby canine kidney cells. Experimental Cell Research. 235: 334-44. PMID 9299157 DOI: 10.1006/excr.1997.3687  0.245
2015 Krishnan V, Xu X, Kelly D, Snook A, Waldman SA, Mason RW, Jia X, Rajasekaran AK. CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia. Molecular Pharmaceutics. 12: 2101-11. PMID 25898125 DOI: 10.1021/Acs.Molpharmaceut.5B00071  0.241
2013 Krishnan V, Xu X, Barwe SP, Yang X, Czymmek K, Waldman SA, Mason RW, Jia X, Rajasekaran AK. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine. Molecular Pharmaceutics. 10: 2199-210. PMID 23194373 DOI: 10.1021/Mp300350E  0.234
1994 Rajasekaran AK, Humphrey JS, Wagner M, Miesenböck G, Le Bivic A, Bonifacino JS, Rodriguez-Boulan E. TGN38 recycles basolaterally in polarized Madin-Darby canine kidney cells. Molecular Biology of the Cell. 5: 1093-103. PMID 7865877 DOI: 10.1091/Mbc.5.10.1093  0.224
2001 Zheng JQ, Kelly TK, Chang B, Ryazantsev S, Rajasekaran AK, Martin KC, Twiss JL. A functional role for intra-axonal protein synthesis during axonal regeneration from adult sensory neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9291-303. PMID 11717363 DOI: 10.1523/Jneurosci.21-23-09291.2001  0.212
1995 Rajasekaran AK, Langhans-Rajasekaran SA, Gould RM, Rodriguez-Boulan E, Morimoto T. A simple biochemical approach to quantitate rough endoplasmic reticulum. The American Journal of Physiology. 268: C308-16. PMID 7864069 DOI: 10.1152/Ajpcell.1995.268.2.C308  0.212
2007 Reckamp KL, Gardner BK, Figlin RA, Elashoff D, Krysan K, Dohadwala M, Inge L, Rajasekaran A, Dubinett SM. Decline in serum soluble E-cadherin and low baseline matrix metalloproteinase-9 are associated with response to combination celecoxib and erlotinib therapy in advanced non-small cell lung cancer Journal of Clinical Oncology. 25: 7640-7640. DOI: 10.1200/Jco.2007.25.18_Suppl.7640  0.167
2002 Jin YP, Singh RP, Du ZY, Rajasekaran AK, Rozengurt E, Reed EF. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. Journal of Immunology (Baltimore, Md. : 1950). 168: 5415-23. PMID 12023334 DOI: 10.4049/Jimmunol.168.11.5415  0.149
1994 Schwartz SB, Higgins PJ, Rajasekaran AK, Staiano-Coico L. Gelsolin expression in normal human keratinocytes is a function of induced differentiation. Advances in Experimental Medicine and Biology. 358: 169-81. PMID 7801803 DOI: 10.1007/978-1-4615-2578-3_16  0.13
2010 Amin R, Bohnert A, Holmes L, Rajasekaran A, Assanasen C. Epidemiologic mapping of Florida childhood cancer clusters. Pediatric Blood & Cancer. 54: 511-8. PMID 20054842 DOI: 10.1002/Pbc.22403  0.119
1995 Rajasekaran AK, Zhou Z, Prakash K, Das G, Kreibich G. Functional characterization of the cis-regulatory elements of the rat ribophorin I gene. Nucleic Acids Research. 23: 313-9. PMID 7885824 DOI: 10.1093/Nar/23.3.313  0.112
2011 Sikes RA, Duncan RL, Lee K, Czymmek K, Steiner K, Rajasekaran AK, Iacocca M, Rabeno B, Catts ZAK, Joseph A, Boman B, Petrelli N. A Collaborative Effort between the Helen F. Graham Cancer Center at Christiana Care, the University of Delaware, and Nemours Biomedical Research Oncology Issues. 26: 22-25. DOI: 10.1080/10463356.2011.11883789  0.056
1991 Sen I, Rajasekaran AK. Angiotensin II-binding protein in adult and neonatal rat heart Journal of Molecular and Cellular Cardiology. 23: 563-572. PMID 1886136 DOI: 10.1016/0022-2828(91)90048-Q  0.052
1995 Abe T, Arakawa Y, Rajasekaran AK, Yu TH, Wada O. Interaction of atrial natriuretic peptide with its receptors in bovine lung membranes. The Journal of Biological Chemistry. 270: 7672-8. PMID 7706315 DOI: 10.1074/jbc.270.13.7672  0.051
2003 Rajasekaran AK, Kirk P, Varshney S. Transient hearing loss with labour epidural block. Anaesthesia. 58: 613-4. PMID 12846648 DOI: 10.1046/j.1365-2044.2003.03207_19.x  0.025
1993 Rajasekaran AK, Maheshwari R. Thermophilic fungi: An assessment of their potential for growth in soil Journal of Biosciences. 18: 345-354. DOI: 10.1007/BF02702992  0.022
2010 Amin R, Bohnert A, Holmes L, Rajasekaran A, Assanasen C. Response to "Childhood clustering in Florida: weighing the evidence". Pediatric Blood & Cancer. 54: 1053. PMID 20405518 DOI: 10.1002/Pbc.22488  0.01
1994 Schwartz SB, Higgins PJ, Rajasekaran AK, Staiano-Coico L. THE 1994 MOYER AWARD Journal of Burn Care & Rehabilitation. 15: 478-485. DOI: 10.1097/00004630-199411000-00004  0.01
Hide low-probability matches.